Antisense Therapeutics’ key anticancer drug trial underway in Melbourne – Proactive Investors Australia
| Proactive Investors Australia Antisense Therapeutics (ASX: ANP) has commenced a Phase 1 Stem Cell Mobilisation Human Proof of Concept trial for its anticancer drug, ATL1102, at the Alfred Hospital in Melbourne. The drug aims to mobilise stem cells from bone marrow into the blood, … |
